Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

LAZ

Lazard Completes $300M Senior Notes Offering

Lazard, Inc. (NYSE: LAZ) announced on August 1, 2025, that its subsidiary Lazard Group LLC has completed its offering of $300,000,000 aggregate principal amount of 5.625% senior notes due 2035. The notes were issued by Lazard Group and were offered pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. The notes are fully and unconditionally guaranteed by Lazard, Inc.

Lazard Group intends to use the net proceeds from the offering to repurchase all of its outstanding 3.625% senior notes due March 1, 2027, that are validly tendered and not validly withdrawn and accepted for purchase pursuant to the tender offer, to pay fees and expenses related to the tender offer, and to use the remaining amount for general corporate purposes.

This announcement comes after Lazard, Inc. previously announced the commencement of a cash tender offer by Lazard Group for any and all of the 2027 notes.

With a history dating back to 1848, Lazard is a leading financial advisory and asset management firm with global operations. The company provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to a wide range of clients.

As of the date of the press release, Lazard did not provide specific metrics or comparisons from the previous period. The market has reacted to these announcements by moving the company's shares -3.44% to a price of $50.19. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS